CPHI [CHINA PHARMAS,] SC 13G/A: (Original Filing)
[CUSIP No. 16941T104]
CPHI [CHINA PHARMAS,] SC 13G/A: CUSIP No. 16941T104
[CUSIP No. 16941T104]
CPHI [CHINA PHARMAS,] SC 13G/A: (Original Filing)
[CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OFOVE PERSONS (ENTITIES ONLY) Peter Siris 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A (SEE INSTRUCTIONS) (a)[_] (b)[X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH]
CPHI [CHINA PHARMAS,] SC 13G/A: CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS
[CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OFOVE PERSONS (ENTITIES ONLY) Peter Siris 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A (SEE INSTRUCTIONS) (a)[_] (b)[X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH]
CPHI [CHINA PHARMAS,] SC 13G/A: (Original Filing)
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 subject to the liabilities]
CPHI [CHINA PHARMAS,] SC 13G/A: reporting person’s initial filing on this form with
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 subject to the liabilities]
CPHI [CHINA PHARMAS,] SC 13G/A: cphi_.txt 1 13G/A
[cphi_.txt 1 13G/A]
CPHI [CHINA PHARMAS,] SC 13G/A: (Original Filing)
[cphi_.txt 1 13G/A]
CPHI [CHINA PHARMAS,] 8-K: (Original Filing)
[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 22, 2010 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 Item 5.07. Submission of Matters to a Vote of Security]
CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORT Date of Report
[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 22, 2010 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 Item 5.07. Submission of Matters to a Vote of Security]
